SCHEMBL5405337

SCHEMBL5405337

CCCCCCCCPc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TP53 P04637 2/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
EPHX2 P34913 1/20 0.39
PKM P14618 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
HTT P42858 2/20 0.38
KCNH2 Q12809 1/20 0.38
NAAA Q02083 1/20 0.38
LIPG Q9Y5X9 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
LTA4H P09960 1/20 0.37
ESR1 P03372 2/20 0.36
ADRA2A P08913 2/20 0.36
ADORA3 P0DMS8 2/20 0.36
TACR2 P21452 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5397657 1.00 DNM1 (0.40) DNM1MEN1KMT2ATP53MAPK1
SCHEMBL27793173 1.00 DNM1 (0.40) DNM1MEN1KMT2ATP53MAPK1
SCHEMBL5389470 1.00 DNM1 (0.40) DNM1MEN1KMT2ATP53MAPK1
SCHEMBL18660546 1.00 DNM1 (0.40) DNM1MEN1KMT2ATP53MAPK1
SCHEMBL5388357 1.00 DNM1 (0.40) DNM1MEN1KMT2ATP53MAPK1
SCHEMBL5393997 1.00 DNM1 (0.40) DNM1MEN1KMT2ATP53MAPK1
SCHEMBL5389878 1.00 DNM1 (0.40) DNM1MEN1KMT2ATP53MAPK1
SCHEMBL5394695 1.00 DNM1 (0.40) DNM1MEN1KMT2ATP53MAPK1
Water SCHEMBL10945410 0.98 HTT (0.41) DNM1MEN1KMT2ATP53MAPK1
Hydrochloric Acid SCHEMBL28979756 0.98 DNM1 (0.39) DNM1MEN1KMT2ATP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990674-A Synthesis of aliphatic aromatic phosphine oxides OCCIDENTAL CHEMICAL CORPORATION (US) 1991-02-05 US claimed
CN-103068807-B By using the preparation method of phenyl substituted heterocycle derivative of coupling process of palladium compound TEIJIN PHARMA LTD. (JP) 2016-05-25 CN disclosed
CN-105506284-A Lanthanide extraction system, extraction method and application thereof UNIV HUBEI SCIENCE & TECH 2016-04-20 CN disclosed
CN-103068807-A Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound TEIJIN PHARMA LTD 2013-04-24 CN disclosed
CN-102333765-A Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst TEIJIN PHARMA LTD 2012-01-25 CN disclosed
US-7214747-B2 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US disclosed
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US disclosed
CN-1046936-C Process for the carbonylation of an acelylenically unsaturated compound ICI LTD (GB) 1999-12-01 CN disclosed
EP-0686063-A1 A METHOD FOR SEPARATING CATALYST FROM A HYDROFORMYLATION REACTION PRODUCT USING ALKYLATED LIGANDS EXXON CHEMICAL PATENTS INC. (US) 1995-12-13 EP disclosed
WO-1994019104-A1 A METHOD FOR SEPARATING CATALYST FROM A HYDROFORMYLATION REACTION PRODUCT USING ALKYLATED LIGANDS EXXON CHEMICAL PATENTS INC. (US) 1994-09-01 WO disclosed
US-4990674-A Synthesis of aliphatic aromatic phosphine oxides OCCIDENTAL CHEMICAL CORPORATION (US) 1991-02-05 US disclosed
EP-0404250-A2 Preparation of N,N-dialkylcarbamoylmethylphosphine oxide AKZO N.V. (NL) 1990-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization CCRL2, ARL1, OSBP2 DNM1 3790/4885MEN1 1786/4885KMT2A 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.